<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Wang Q</dc:creator>
  <dc:creator>Sachse P</dc:creator>
  <dc:creator>Semmo M</dc:creator>
  <dc:creator>Lokhande M</dc:creator>
  <dc:creator>Montani M</dc:creator>
  <dc:creator>Dufour JF</dc:creator>
  <dc:creator>Zoulim F</dc:creator>
  <dc:creator>Klenerman P</dc:creator>
  <dc:creator>Semmo N</dc:creator>
  <dc:date>2015</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">A serologic response to hepatitis B virus (HBV) defined as 'anti-HBc alone' is commonly observed, but its significance remains unclear. This study aimed to define the relationship between 'anti-HBc alone' serostatus and HBV infection, including HBV-specific T- and B-cell memory responses. We enrolled 31 'anti-HBc alone' patients. Total HBV DNA and cccDNA were tested by nested polymerase chain reaction (PCR) analysis in liver samples from 22 'anti-HBc alone' patients vs controls (chronic or resolved HBV infection), followed by HBsAg/HBcAg immunohistochemical (IHC) staining. IFN-γ secretion by HBV-specific T cells was compared in individuals who were 'anti-HBc alone' (n = 27), resolved HBV (n = 21), chronic HBV (n = 24) and 12 healthy controls using enzyme-linked immunospot (ELISpot) assays. An HBsAg-IgG B-cell ELISpot assay was performed in 'anti-HBc alone' patients before and after one dose of recombinant HBsAg vaccine. The majority (23/31, 74.2%) of the 'anti-HBc alone' individuals were co-infected with HCV. Infrequent intrahepatic total HBV DNA (2/22, 9.1%) and cccDNA (1/22, 4.5%) were detected in biopsies; HBsAg and HBcAg IHC staining was negative. HBV-specific T-cell responses were similar between 'anti-HBc alone' individuals and HBV resolvers. Circulating HBV-memory B-cell responses were detected in all 'anti-HBc alone' individuals, consistent with an HBsAg-specific memory pool. After one HBV vaccine dose, increased anti-HBs antibody levels were observed, accompanied by an expansion of HBsAg-specific memory B cells (P = 0.0226). 'Anti-HBc alone' individuals showed HBV-specific T-cell and memory B-cell responses typical of previous viral exposure and protective memory, suggesting a resolved infection.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/263725</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1111/jvh.12428</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/26075501</dc:relation>
  <dc:source>Journal of viral hepatitis. - 2015</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">T cells</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">anti-HBc alone</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">hepatitis B</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">memory B cells</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Antibodies, Viral</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">B-Lymphocytes</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Hepatitis B Antibodies</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Hepatitis B Core Antigens</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Hepatitis B Surface Antigens</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Hepatitis B Vaccines</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Hepatitis B virus</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Hepatitis B, Chronic</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Immunohistochemistry</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Interferon-gamma</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">T-Lymphocytes</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Vaccination</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Viral Load</dc:subject>
  <dc:title xmlns:ns23="xml" ns23:lang="en">T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
